Schaenman J, Liao D, Phonphok K, Bunnapradist S, Karlamangla A
Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Transplant Proc. 2019 Apr;51(3):684-691. doi: 10.1016/j.transproceed.2019.01.035. Epub 2019 Jan 9.
Older kidney patients with chronic kidney disease benefit significantly from kidney transplantation. However, these older transplant recipients have greater mortality after transplantation than younger transplant recipients. Understanding the impact of comorbidities on post-transplant mortality can improve risk stratification and patient selection.
A single-center analysis of 3105 kidney transplant recipients was performed over a 12-year period. Comorbidities associated with death were evaluated in older and younger transplant recipients.
The 2 most important factors associated with increased mortality in the first 100 days after transplant were recipient age ≥60 and receipt of deceased donor organs (adjusted odds ratios, 3.29 and 5.80, respectively), with no statistically significant impact of recipient comorbidities. In the later post-transplant period (after the first 100 days), recipient age ≥60 and receipt of deceased donor organs (adjusted hazard ratios [HR] of 2.14 and 2.29, respectively) remained predictors of mortality. We also found that donor age ≥60 and the recipient having cardiovascular disease and diabetes were independent predictors of increased mortality. There was a statistically significant interaction between diabetes and heart disease and recipient age ≥60, with a lesser impact on late mortality in older patients compared to younger patients.
This analysis suggests that comorbidities have a larger impact later after transplantation, with less effect on older recipients. These observations suggest that certain comorbid conditions should be evaluated differently in older patients compared to younger ones.
老年慢性肾脏病患者可从肾移植中显著获益。然而,这些老年肾移植受者移植后的死亡率高于年轻受者。了解合并症对移植后死亡率的影响有助于改善风险分层和患者选择。
对3105例肾移植受者进行了为期12年的单中心分析。评估了老年和年轻移植受者中与死亡相关的合并症。
移植后100天内与死亡率增加相关的2个最重要因素是受者年龄≥60岁和接受已故供者器官(校正比值比分别为3.29和5.80),受者合并症无统计学显著影响。在移植后期(100天后),受者年龄≥60岁和接受已故供者器官(校正风险比[HR]分别为2.14和2.29)仍是死亡率的预测因素。我们还发现供者年龄≥60岁以及受者患有心血管疾病和糖尿病是死亡率增加的独立预测因素。糖尿病与心脏病和受者年龄≥60岁之间存在统计学显著的相互作用,与年轻患者相比,对老年患者晚期死亡率的影响较小。
该分析表明,合并症在移植后期影响更大,对老年受者的影响较小。这些观察结果表明,与年轻患者相比,老年患者某些合并症的评估应有所不同。